| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/22/2007 | US20070044163 Interferon gamma-like protein |
| 02/22/2007 | US20070044162 Transgenic rat as animal model for human huntingdon's disease |
| 02/22/2007 | US20070043218 reacting tetrachloroperylene-3,4:9,10-tetracarboxylic bisanhydride, diisopropylaniline and butyroaniline in propionic acid to produce N-(2,6-diisopropylphenyl)-N'-[(4-butyric acid)phenyl]-1,6,7,12-tetrachloroperylene-3,4:9,10-tetracarboxylic acid bisimide; thermal, chemical and photophysical stability |
| 02/22/2007 | US20070043216 Recovering ribonucleic acid sequences from matrix; mixing biological material with buffered RNA lysing/binding solution; incubate with matrix; preferentially elute RNA from matrix; nucleic acid isolation |
| 02/22/2007 | US20070043215 Recombinant f1-v plague vaccine |
| 02/22/2007 | US20070043212 Crown ether derivatives |
| 02/22/2007 | US20070043211 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070042986 Methods of inhibiting VEGF-C |
| 02/22/2007 | US20070042985 Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field |
| 02/22/2007 | US20070042984 gene expression inhibition; 5'-nucleotide in 5'-ua-3' motifs in antisense strand are 2'-O-methyl modified, and every pyrimidine in sense strand except for deoxythimidine is 2'-O-methyl modified; isolated cells |
| 02/22/2007 | US20070042983 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/22/2007 | US20070042982 Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof |
| 02/22/2007 | US20070042980 Gp131: methods and compositions for treating cancer |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |
| 02/22/2007 | US20070042977 Vaccine |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042958 Immunoglobulins; myostatins; for treatment of neuronal diseases, muscle and bone conditions, and metabolic disorders; improved solubility, pharmacokinetics |
| 02/22/2007 | US20070042954 Soluble G-protein coupled receptors (sGPCR); corticotropin releasing factor receptor type 2 (sCRFR2) attached to affinity tag, fluorescent label, immunoglobulin domain or conjugated to polyoxyethylene glycol; skin, gastrointestinal, bipolar, and psychological disorders; drug abuse; anxiolytic agents |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042941 Galectin 9-inducing factors |
| 02/22/2007 | US20070042476 nucleotide sequence encoding a malic enzyme B having the activity of converting pyruvic acid or pyruvate to malic acid or malate, or vice versa, a recombinant vector containing the gene, a microorganism transformed with recombinant vector, and preparing succinic acid using the transformed microorganism |
| 02/22/2007 | US20070042474 Corynebacterium glutamicum genes encoding novel proteins |
| 02/22/2007 | US20070042472 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070042471 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070042470 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070042469 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 02/22/2007 | US20070042468 Interferon-like protein zcyto21 |
| 02/22/2007 | US20070042467 NIMA interacting proteins |
| 02/22/2007 | US20070042466 Il-1 related polypeptides |
| 02/22/2007 | US20070042465 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070042464 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 02/22/2007 | US20070042463 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof |
| 02/22/2007 | US20070042461 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 02/22/2007 | US20070042457 Process for producing penicillin |
| 02/22/2007 | US20070042445 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 02/22/2007 | US20070042435 Assays for sensory modulators using a sensory cell specific G-protein beta subunit |
| 02/22/2007 | US20070042433 Neuregulin protein regulation of synaptic proteins |
| 02/22/2007 | US20070042422 Used for the rapid identification of frequently occurring bacteria, viruses and fungi |
| 02/22/2007 | US20070042420 Liver tumor marker sequences |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042415 Anti-fused antibodies |
| 02/22/2007 | US20070042413 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/22/2007 | US20070042412 Detection of biologically active compounds |
| 02/22/2007 | US20070042407 Modified nucleosides and nucleotides and uses thereof |
| 02/22/2007 | US20070042404 Compositions and method for detecting endonuclease activity |
| 02/22/2007 | US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 02/22/2007 | US20070042395 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 02/22/2007 | US20070042394 Apparatus for producing a DNA doped carbon cluster and method for producing the same |
| 02/22/2007 | US20070042391 useful as molecular targets for diagnostics, prophylaxis and treatment of pathological conditions; for use in generating agents for prevention and treatment of infection |
| 02/22/2007 | US20070042387 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/22/2007 | US20070042386 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system |
| 02/22/2007 | US20070042385 Novel compositions and methods in cancer |
| 02/22/2007 | US20070042384 Method for isolating and modifying DNA from blood and body fluids |
| 02/22/2007 | US20070042383 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 02/22/2007 | US20070042382 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 02/22/2007 | US20070042381 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof |
| 02/22/2007 | US20070042380 Genomic Address Messenger or GAM oligonucleotide; human regulatory microRNA-like (miRNA) oligonucleotides; anneals to a portion of a mRNA transcript of a target gene associated with Multiple Sclerosis |
| 02/22/2007 | US20070042379 having at least 35% amino acid sequence identity with T7 Endo I, two catalytic centers separated by a beta -bridge, and a mutation of at least one amino acid in the beta -bridge that has an effect of altering cleavage activity; reduced toxicity in a host cell permitting over-expression of the enzyme |
| 02/22/2007 | US20070042378 Regulation of prokaryotic gene expression with zinc finger proteins |
| 02/22/2007 | US20070042375 Isolated berovin photoprotein and use thereof |
| 02/22/2007 | US20070042372 Method for designing dna codes used as information carrier |
| 02/22/2007 | US20070042371 Mptens as modifers of the pten/igf pathway and methods of use |
| 02/22/2007 | US20070042370 Fluorescent substrates for detecting organophosphatase enzyme activity |
| 02/22/2007 | US20070042368 Detection and monitoring of lung cancer |
| 02/22/2007 | US20070042365 Assay for detecting methylation changes in nucleic acids using an intercalating nucleic acid |
| 02/22/2007 | US20070042363 Novel polypeptide and nucleic acid encoding the same |
| 02/22/2007 | US20070042359 E-protein specific immunoglobulin for use in treatment and prevention of viral infection |
| 02/22/2007 | US20070042356 Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 02/22/2007 | US20070042354 Detecting pathogens in companion animals |
| 02/22/2007 | US20070042345 Polypeptide having intracellular calcium ion indicator function |
| 02/22/2007 | US20070042080 Novel food production process |
| 02/22/2007 | US20070042050 Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression |
| 02/22/2007 | US20070042047 Vaccines |
| 02/22/2007 | US20070042002 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070042001 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070042000 Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142 |
| 02/22/2007 | US20070041991 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine |
| 02/22/2007 | US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
| 02/22/2007 | US20070041982 ILT3 binding molecules and uses therefor |
| 02/22/2007 | US20070041980 CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/22/2007 | US20070041977 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/22/2007 | US20070041972 Antibodies and fusion proteins that include engineered constant regions |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041966 Polypeptides including modified constant regions |
| 02/22/2007 | US20070041965 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041963 Human secreted proteins |
| 02/22/2007 | US20070041958 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 02/22/2007 | US20070041946 Serotype of adenovirus and uses thereof |
| 02/22/2007 | US20070041941 Nucleic acid sequences encoding and compositions comrpising ige signal peptide and/or il-15 and methods for using the same |
| 02/22/2007 | US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | DE10253351B4 Neuartige Pufferfomulierungen zur Isolierung, Reinigung und Rückgewinnung lang- und kurzkettiger Nukleinsäuren Novel Pufferfomulierungen for the isolation, purification and recovery of long- and short-chain nucleic acids |
| 02/22/2007 | CA2656705A1 Influenza recombinant subunit vaccine |
| 02/22/2007 | CA2619663A1 Human ribosomal dna(rdna) and ribosomal rna (rrna) nucleic acids and uses thereof |
| 02/21/2007 | EP1754787A2 Methods for producing members of specific binding pairs |
| 02/21/2007 | EP1754052A1 Modulators of biochemical characteristics |
| 02/21/2007 | EP1753882A2 Gene expression and polymorphisms associated with lung cancer |